Trials / Withdrawn
WithdrawnNCT00584246
Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of Pregabalin (Lyrica) in treating patients with Restless Legs Syndrome (RLS) in a double-blind, placebo-controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin (Lyrica) | 50 - 150 mg po qhs for 2 months |
| DRUG | Placebo | 50 - 150 mg po qhs for 2 months |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-01-02
- Last updated
- 2021-11-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00584246. Inclusion in this directory is not an endorsement.